“One of the things we’ve spent a lot of time thinking about in the last many months — and we’re going to continue this work, and you’ll hear more from the administration on this — is getting us out of that acute emergency phase where the U.S. government is buying the vaccines, buying the treatments, buying the diagnostic tests,” Dr. Jha said.
“My hope is that in 2023, you’re going to see the commercialization of almost all of these products. Some of that is actually going to begin this fall in the days and weeks ahead. You’re going to see the commercialization of some of these things,” he continued.
“We’re still working on trying to pull more resources from other places,” he said. “I would like to get to a point where every adult in America who wants a vaccine can get one. I’m hopeful we will be there. We’re not quite there yet in terms of how many vaccine doses we’ve been able to buy.”
“What’s really limited us is a lack of resources, but we are pulling from other high-priority items. So my hope is that we’re going to be able to have this for every single adult in America. We will know more about that in the upcoming weeks, I think,” he added.
“Our healthcare system is going to get into serious trouble unless we are very proactive about preventing it — so if we do nothing and just sort of hope for the best, I think we could end up getting into a lot of trouble this fall and winter,” Dr. Jha said.
Discover more from Baller Alert
Subscribe to get the latest posts sent to your email.
